SUMOylation of DISC1: a potential role in neural progenitor proliferation in the developing cortex by Tankou, Stephanie et al.
 
 
 
 
 
Tankou, S. et al. (2016) SUMOylation of DISC1: a potential role in neural 
progenitor proliferation in the developing cortex. Molecular Neuropsychiatry, 2(1), 
pp. 20-27. 
 
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
 
 
 
 
 
http://eprints.gla.ac.uk/115761/ 
     
 
 
 
 
 
 
Deposited on: 1 February 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
1 
SUMOylation of DISC1: 
a potential role in neural progenitor proliferation in the developing cortex 
 
Stephanie Tankou
a,h
, Kazuhiro Ishii
a
, Christina Elliott
b
, Krishna C. Yallab, Jon P. Dayb,  
Keiko Furukori
a
, Ken-ichiro Kubo
c
, Nicholas J. Brandon
d
, Qiyi Tang
e
, Gary Hayward
f
, Kazunori 
Nakajima
c
, Miles D. Houslayg, Atsushi Kamiya
a
, George Baillieb, Koko Ishizuka
a
, and Akira Sawa
a,i 
 
Departments of 
a
Psychiatry and 
f
Pharmacology, The Johns Hopkins University, Baltimore, MD, USA 
b
Molecular Pharmacology Group, CMVLS, University of Glasgow, Glasgow, UK 
c
Department of Anatomy, Keio University School of Medicine, Tokyo, Japan 
d
AstraZeneca Neuroscience iMED, Cambridge, MA, USA 
e
Department of Microbiology, Howard University College of Medicine, Washington, DC, USA 
g
Institute of Pharmaceutical Sciences, King’s College London, London, UK 
h
Present address: Center of Neurological diseases, Harvard University, Cambridge, MA, USA 
i
Corresponding author: Akira Sawa, MD, PhD, asawa1@jhmi.edu 
 
 
Short title: SUMOylation of DISC1 
Key words: DISC1, SUMOylation, post-translational modification, cortical development, mental illness 
 
 
 
 
 
 
 
2 
 
Abstract  
DISC1 is a multifunctional, intracellular scaffold protein. At the cellular level, DISC1 plays a pivotal 
role in neural progenitor proliferation, migration, and synaptic maturation. Perturbation of the biological 
pathways involving DISC1 is known to lead to behavioral changes in rodents, which supports a clinical 
report of a Scottish pedigree in which the majority of family members with disruption of the DISC1 
gene manifest depression, schizophrenia, and related mental conditions. The discrepancy of modest 
evidence in genetics but strong biological support for the role of DISC1 in mental conditions suggests a 
working hypothesis that regulation of DISC1 at the protein level, such as posttranslational modification, 
may play a role in the pathology of mental conditions. In this study, we report the SUMOylation of 
DISC1. This posttranslational modification occurs on lysine residues where small ubiquitin-related 
modifier (SUMO) and its homologs are conjugated to a large number of cellular proteins, which in turn 
regulates their subcellular distribution and protein stability. By using in silico, biochemical, and cell 
biological approaches, we now demonstrate that human DISC1 is SUMOylated at one specific lysine 
643 (K643). We also show that this residue is crucial for proper neural progenitor proliferation in the 
developing cortex. 
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Introduction 
Over the past several decades, we have used genetic and neuropathological approaches to explore 
compelling molecular leads to address the mechanisms of neurological and neuropsychiatric disorders 
[1-3].  For example, tau and α-synuclein proteins have been underscored as major components of 
inclusion bodies that occur in the brains of patients with Alzheimer’s disease and Parkinson’s disease, 
respectively [4, 5]. The tau and α-synuclein proteins are pathologically phosphorylated [6, 7], and the 
pathological roles of these posttranslational modifications have been elucidated [8]. Likewise, 
pathological implications of other posttranslational modifications have also been reported [9].   
 The DISC1 locus has received broad attention in the context of psychiatric illness, since a 
balanced translocation that segregated in a Scottish pedigree with schizophrenia and depression was 
reported [10]. Since the discovery of the gene, many neurobiologists have studied the biological function 
of DISC1. At the cellular level, DISC1 plays a pivotal role in neural progenitor proliferation, migration, 
and synaptic maturation [11, 12]. Perturbation of the biological pathways involving DISC1 is known to 
lead to behavioral changes in rodents [13-21]. In contrast to biological results that support the role for 
DISC1 in mental conditions, genetic evidence to support the contribution of the DISC1 gene in sporadic 
schizophrenia has been modest [22]. The discrepancy of modest evidence in genetics but strong 
biological support for the role of DISC1 in mental conditions led us to propose a working hypothesis 
that regulation of DISC1 at the protein level, such as posttranslational modification, may play a role in 
its function in pathology.  
 DISC1 is located in multiple subcellular domains, including the centrosome, postsynaptic 
density, and the nucleus [11, 23, 24]. Like tau and α-synuclein, specific phosphorylation on DISC1 
affects its localization to the centrosome and plays a crucial role in neurodevelopment [25]. Protein 
targeting to the nucleus is also influenced by posttranslational modifications, such as SUMOylation [26]. 
SUMOylation occurs on lysine residues whereby small ubiquitin-related modifiers (SUMO) and 
homologs are conjugated to proteins [27]. SUMOylation has emerged as a major regulator of nuclear 
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function, including DNA replication, DNA damage response, and transcription [28-30]. Furthermore, an 
important role for SUMOylation in protein trafficking to the nucleus has also been reported [31].  
 In the present study, we show that human DISC1 is SUMOylated at lysine 643 (K643) with in 
silico, biochemical, and cell biological approaches. This specific SUMOylation site of DISC1 regulates 
neural progenitor proliferation in the developing cortex. 
 
Methods 
Animals 
Pregnant C57BL/6 mice were purchased from Charles River. 
 
Constructs and antibodies 
A K643A variant of human DISC1 or a K640A variant of mouse DISC1 (mDISC1) was introduced by 
PCR-based mutagenesis as mentioned previously [25]. All constructs in the present study were created 
as described previously [24, 32]. We used short hairpin RNA (shRNA) construct of DISC1 that was 
published previously (targeting sequence is 5'-GGCAAACACTGTGAAGTGC-3') [24]. We used a 
control RNAi construct with a scrambled sequence without homology to any known messenger RNA 
[33]. GFP-tagged SUMO1, FLAG-tagged SUMO1, and Myc-tagged Ubc9 constructs were generous 
gifts from Dr. Pandolfi (Beth Israel Deaconess Cancer Center, USA), Dr. Hayward (Johns Hopkins 
University, USA), and Dr. Matunis (Johns Hopkins School of Public Health, USA), respectively. The 
following antibodies were used: mouse monoclonal anti-HA antibody (Covance); rabbit polyclonal anti-
FLAG antibody (Sigma); rabbit polyclonal anti-SUMO1 antibody (Zymed); mouse monoclonal anti-
BrdU antibody (BD Biosciences); anti-DISC1-C2 antibody [34]; and a rabbit polyclonal anti-human 
DISC1 antibody (kindly provided by Dr. Akiyama, University of Tokyo) [35-37].  
 
In silico prediction of SUMOylation site(s) in DISC1 
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Prediction of DISC1 SUMOylation sites was determined by using the SUMOplot
TM
 Analysis Program 
from ABGENT available at http://www.abgent.com/sumoplot. The score indicates the probability that 
the targeted lysine is SUMOylated. 
 
Recombinant proteins 
To obtain C-terminal DISC1 fragmented glutathione S-transferase (GST) fusion proteins, the C-terminal 
of DISC1 (amino acids 598-854) was inserted into pGEX vector. The expression plasmids were 
introduced into BL21 competent E. coli with 0.1 mM IPTG. Recombinant proteins were purified from 
E. coli with glutathione sepharose or amylase beads. 
 
In vitro SUMOylation assay 
In vitro SUMOylation was assayed by use of the SUMOylation assay kit (Boston Biochem). Briefly, 
reactions contained 10 µg of GST-DISC1-C, 50 µM SUMO proteins, 100 nM SUMO activating 
enzyme, E1, 5 µM Ubc9, and 1mM Mg-ATP in buffer (50 mM HEPES, pH 8.0, 100 mM NaCl, 1 mM 
DTT), and were incubated at 37˚C for 2 h. The reactions were also run in the absence of ATP as a 
negative control. Proteins were separated on a NuPAGE 4-12% Bis-Tris gel (Invitrogen) and visualized 
with SimplyBlue SafeStain (Invitrogen). For Western blotting, an 8% Tris-Glycine gel (Invitrogen) was 
used. 
 
Ubc9 fusion-directed SUMOylatin (UFDS) assay 
UFDS assay was performed as previously described [32] with minor modifications. Briefly, HEK293 
cells were transfected with the construct of DISC1-Ubc9 or DISC1-Ubc9 (C93S) together with the 
SUMO1-GFP construct, and lysed 48 h after transfection. Immunoblots were conducted with the anti-
DISC1 antibody described above [35]. 
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Cell culture 
COS7 cells were used to assay SUMOylation on DISC1. Cells were grown in Dulbecco’s modified 
Eagle's medium (DMEM) with 10% FBS. The expression constructs were transfected into cells by using 
FuGENE
®
6 (Roche Applied Sciences). U373 cells were transfected with a DISC1 or DISC1-K643A 
construct to examine the nuclear translocation of SUMOylated DISC1. Cells were immunostained as 
previously described [25]. The intensity of immunostaining of DISC1 in the nucleus versus the whole 
cell was quantified with Metamorph (Molecular Devices) for all experimental groups. The intensity ratio 
of the signal for at least 30 cells per group was analyzed in three independent experiments.  
 
Immunoprecipitation 
Cells were lysed in a RIPA buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 5 mM DTT, 1 
mM PMSF, 1 mM EDTA, 1% Triton X-100) containing protease inhibitor mixture (Roche Applied 
Sciences). Supernatant fractions were obtained from lysates after centrifugation at 13 000 rpm for 15 
min. Soluble fractions were used for immunoprecipitation as described previously [25]. 
 
In utero electroporation 
Pregnant C57BL/6 mice at embryonic (E) day 13 were deeply anesthetized by intraperitoneal 
administration of 2,2,2-tribromoethanol in tert-amyl alcohol (0.4 mg/g), and intrauterine embryos were 
surgically manipulated as described previously [24, 38]. Plasmid solutions in volumes of 1-2 µl 
containing RNAi plasmids (2 µg/µl) together with CAG-driven mDISC1 with mutations in RNAi 
targeting site expression vector (1 µg/µl) and/or CAG-driven GFP expression vector (1 µg/µl) were 
injected into the lateral ventricles. To use the same amount of DNA for each condition, an empty 
expression vector (pCAGGS1) was used as necessary. Electronic pulses (35 V, 50 ms, 4 times) were 
applied using an electroporator (CUY21E, Tokiwa Science) with forceps-type electrode (CUY650-5, 
Tokiwa Science). 
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BrdU incorporation assay and brain slice preparation 
Incorporation of BrdU was assayed was performed as previously described [25] with minor 
modifications. 50 mg/kg BrdU (Sigma) was injected intraperitoneally into E13 pregnant mice 48 h after 
electroporation. Then 2 h after BrdU injection, brains were fixed with 4% paraformaldehyde, and 20 µm 
coronal sections were obtained with a cryostat (CM 1850, Leica). For BrdU immunostaining, brain 
slices were incubated in 2 N HCl at 37˚C for 30 min before incubation with mouse anti-BrdU antibody. 
Images of the slices were acquired with a confocal microscope (Zeiss LSM510 and Olympus FV300). 
 
Statistical analysis 
To compare four groups, one-way ANOVA followed by Bonferroni post hoc for multiple comparisons 
test was used. p < 0.05 were considered to be statistically significant (*p < 0.05). 
 
Results 
SUMOylation of C-terminal DISC1 at lysine residue 643 (K643) in vitro 
DISC1 is found at multiple subcellular domains, and its nuclear localization and biological roles have 
been demonstrated [22]. This subcellular targeting may be determined in part by posttranslational 
modifications [25]. As a role of SUMOylation for targeting proteins to the nucleus is known [26], we 
hypothesized that a pool of DISC1 may be SUMOylated. We thus first predicted the SUMOylation 
site(s) in DISC1 by using a bioinformatics approach with the ABGENT SUMOplot 
(http://www.abgent.com/sumoplot). By this method, DISC1 at lysine residue 643 (K643) was identified 
as a strong candidate SUMOylation site (fig. 1a). Since K643 is in the C-terminus of DISC1, we assayed 
in vitro SUMOylation with GST-tagged C-terminal DISC1 protein spanning amino acid residues 598-
854 (DISC1-C). In the presence of ATP, which is crucial for SUMO-protein conjugation, DISC1-C was 
SUMOylated by SUMO1, SUMO2, or SUMO3 (fig. 1b). Next, to confirm whether K643 is essential for 
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SUMOylation in DISC1-C, we performed in vitro SUMOylation assays using mutant DISC1-C where 
lysine residue 643 was substituted into alanine (DISC1-C-K643A). Even in the presence of ATP, 
DISC1-C-K643A was not SUMOylated by SUMO1 (fig 1c). These results were consistent after 
normalization of the SUMOylated DISC1-C signals by the amount of non-SUMOylated form of DISC1-
C (cyan arrow head in fig. 1c). Thus, these results indicate that C-terminal DISC1 protein is 
SUMOylated at lysine residue 643 in vitro. 
 
SUMOylation of DISC1 at K643 in cells 
Next, to test whether the SUMOylation of DISC1 occurs in cells, we exogenously expressed DISC1-C 
together with SUMO1 in cells and examined whether DISC1-C is conjugated to SUMO. DISC1-C and 
SUMO1 were indeed co-immunoprecipitated, and a signal for the immunoprecipitated protein complex 
was observed (red arrowhead in IP panel in fig. 2a). Of note, a signal for SUMOylation of DISC1-C was 
also observed in the lysates (red arrowhead in Input panel in fig. 2a). Then, to determine whether K643 
is the SUMOylation site in DISC1-C in cells, we examined whether the mutation in which lysine residue 
643 was replaces with alanine (K643A) in C-terminal of DISC1 interfered with the SUMOylation. 
Immunoblotting with cells transfected with DISC1-C showed a strong signal that represents 
SUMOylated DISC1-C, whereas such a signal was abolished in cells expressed with DISC1-C-K643A 
(fig. 2b). These results suggest that the SUMOylation of DISC1-C occurs at lysine residue 643 in cells.  
 We next assessed whether the full-length DISC1 could also be SUMOylated in cells. Strong 
signal that represents SUMOylated DISC1 was detected when DISC1-Ubc9, which enhances the 
SUMOylation, was exogenously expressed together with SUMO1 in cells (red arrowhead). This 
SUMOylation on DISC1 was abolished by co-expression of SUMO1 with DISC1-Ubc9 (C93S), a 
dominant negative form of Ubc9 (fig. 2c).  
To address the question whether K643 is the main SUMOylation site on full-length DISC1, we 
compared potential SUMOylation between wild-type full-length DISC1 (DISC1) and full-length DISC1-
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K643A (DISC1-K643A). Cells were co-expressed with DISC1 or DISC1-K643A together with SUMO1 
and Ubc9. DISC1 and SUMO1 were co-immunoprecipitated, and a signal for the immunoprecipitated 
protein complex was observed (red arrowhead in IP panel in fig. 2d), whereas such a signal was 
abolished in cells expressed with DISC1-K643A. These results were consistent after normalization of 
the SUMOylated DISC1 signals by the amount of non-SUMOylated form of full-length DISC1 (cyan 
arrow heads in fig. 2d). Of note, a signal for SUMOylation of DISC1 was also observed in the lysates 
(red arrowhead in Input panel in fig. 2d). On the basis of these results, K643 is considered the main 
SUMOylation site on full-length DISC1. 
 
K640 SUMOylation site in mouse DISC1 (mDISC1) (corresponding to K643 in human DISC1) is crucial 
for proper proliferation of neural progenitor cells (NPCs) in the developing cortex 
As DISC1 is reportedly located in multiple subcellular domains [11, 23, 24], we tested possible 
influence of SUMOylation on the subcellular distribution of DISC1. We observed decreased nuclear 
targeting of DISC1-K643A compared to wild-type DISC1, suggesting that SUMOylation at K643 in 
human DISC1 (corresponding to K640 in mouse DISC1) may play a role in the nuclear localization of 
DISC1 (online suppl. fig. 1). 
Previous studies have shown that DISC1 modulates NPCs proliferation in vivo [25, 39]. Thus, 
We tested how the K640 SUMOylation site in mDISC1 affected the proliferation of NPCs by in utero 
gene transfer combined with BrdU pulse-labeling. Consistent with our previous study [25], the 
proportion of cells incorporating BrdU was significantly decreased in brains with mDISC1 knockdown 
(mDISC1 RNAi) compared to control, indicating that NPC proliferation was impaired. These 
knockdown effects were ameliorated by co-expression with wild type mDISC1, but not by mDISC1-
K640A (fig. 3), suggesting that the K640 SUMOylation site in mDISC1 is crucial for proper 
proliferation of NPCs in the developing cortex.  
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Discussion 
Here we report that DISC1 protein is SUMOylated. By combining in silico, biochemical, and cell 
biological approaches, we have determined that lysine 643 in human DISC1 (which corresponds to 
lysine 640 in mouse DISC1) is a major SUMOylation site. We show that mutation in this residue leads 
to cellular deficits, including improper neural progenitor proliferation in the developing cortex.  
 In our biochemical analysis, the levels of SUMOylation at DISC1-K643 were relatively modest. 
It is known that, in general, a small pool of SUMOylated protein can have significant biological effects 
[40]. Therefore, the small population of SUMOylated DISC1 might have important biological effects. In 
cell cultures, we observed that the mutation at the lysine residue for the critical SUMOylation affected 
nuclear localization of DISC1. Thus far, several papers have indicated a role for nuclear DISC1 [25, 39]. 
By examining autopsied brains from patients with neuropsychiatric conditions, Sawamura et al. [41] 
suggested that nuclear DISC1 in the orbitofrontal cortex may be involved in substance abuse. The 
Furukubo-Tokunaga lab [42] reported that DISC1 is involved in the regulation of sleep homeostasis, in 
particular in association with nuclear DISC1. More recently, the Tsai lab [43] has demonstrated that 
nuclear DISC1 is crucial for the regulation of phosphodiesterase-cyclic AMP signaling that underlies 
multiple psychiatric conditions. Taken together, although each study is still independent without a 
cohesive or integrative story of nuclear DISC1 function yet, studying nuclear DISC1 will be important 
in studying the pathological mechanisms for mental illnesses. We hope that SUMOylation at K643 in 
human DISC1 may be a solid molecular probe to lead such mechanistic studies.   
 In addition, we observed that the replacement of lysine with alanine at a critical SUMOylation 
site (mouse K640 that corresponds to human K643) disturbed neural progenitor proliferation in the 
developing cortex. In the experiments, we used in utero electroporation with DISC1-RNAi and 
expression constructs. The knockdown effect by the DISC1-RNAi construct used in the current study 
has been fully validated by multiple groups [11, 24, 25, 39]. Furthermore, DISC1 knockdown-mediated 
aberrant neural progenitor proliferation has been shown with multiple RNAi constructs targeting 
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different regions of DISC1, and been rescued by co-expressing the full-length isoform of DISC1 in the 
present and previous studies [25, 39]. Although the significant influence of mouse DISC1-K640 is not a 
direct demonstration that SUMOylation of DISC1 is crucial for the neurodevelopmental process, we 
believe this is very suggestive evidence. To address this question in a more direct manner, although it is 
beyond the scope of the present study, we may need to develop anti-SUMOylation specific DISC1 
antibodies. Equivalent antibodies have been frequently used as tools to study protein phosphorylation 
[44], and indeed applied to a study in DISC1 in the past [25]. There is thus a successful precedence for 
using anti-SUMOylation specific antibodies in biomedical studies [7, 45]. Such posttranslational 
modification-specific antibodies may become useful probes to study the pathology of mental illness.  
 
Acknowledgements 
We thank Ms. Y. Lema for preparing figures and organizing the manuscript, Drs. P. Talalay and N.J. 
Gamo for critical reading of this manuscript. This work was supported by USPHS grants of MH084018 
Silvio O. Conte center (A.S.), MH094268 Silvio O. Conte center (A.S. and A.K.), MH069853 (A.S.), 
MH085226 (A.S.), MH088753 (A.S.), MH092443 (A.S.), MH091230 (A.K.), MH96208 (K.I.), 
MH105660 (A.S. and K.I.); grants from Stanley, RUSK, S-R, and DANA foundations (A.S.); grants 
from NARSAD (A.S., A.K., and K.I.); grants from MSCRF (A.S. and K.I.); the Grand Challenge 
Programme grants from Pfizer (G.B.). 
 
Statement of Ethics 
All animal care and use was in accordance with guidelines for the care and use of laboratory animals 
issued by the National Institutes of Health and Johns Hopkins University. The authors have no ethical 
conflicts to disclose. 
 
Disclosure Statement 
12 
Nicholas Brandon is a full-time employee and a shareholder at AstraZeneca. The other authors have no 
conflicts of interest to report. 
 
References 
1. Samii A, Nutt JG, Ransom BR: Parkinson's disease. Lancet 2004;363:1783-93. 
2. Insel TR: Rethinking schizophrenia. Nature 2010;468:187-93. 
3. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E: Alzheimer's disease. Lancet 
2011;377:1019-31. 
4. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI: Abnormal 
phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal 
pathology. Proc Natl Acad Sci U S A 1986;83:4913-7. 
5. Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, 
Trojanowski JQ, Lee VM: Exogenous alpha-synuclein fibrils induce Lewy body pathology 
leading to synaptic dysfunction and neuron death. Neuron 2011;72:57-71. 
6. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM: Microtubule-
associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 
1986;261:6084-9. 
7. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio 
K, Iwatsubo T: alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 
2002;4:160-4. 
8. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, 
Winblad B: Defective brain microtubule assembly in Alzheimer's disease. Lancet 1986;2:421-6. 
9. Haj-Yahya M, Fauvet B, Herman-Bachinsky Y, Hejjaoui M, Bavikar SN, Karthikeyan SV, 
Ciechanover A, Lashuel HA, Brik A: Synthetic polyubiquitinated alpha-Synuclein reveals 
13 
important insights into the roles of the ubiquitin chain in regulating its pathophysiology. Proc 
Natl Acad Sci U S A 2013;110:17726-31. 
10. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ: 
Association within a family of a balanced autosomal translocation with major mental illness. 
Lancet 1990;336:13-6. 
11. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ, Makino Y, 
Seshadri AJ, Ishizuka K, Srivastava DP, Xie Z, Baraban JM, Houslay MD, Tomoda T, Brandon 
NJ, Kamiya A, Yan Z, Penzes P, Sawa A: Disrupted-in-Schizophrenia 1 (DISC1) regulates 
spines of the glutamate synapse via Rac1. Nat Neurosci 2010;13:327-32. 
12. Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y, Kim NS, Yoon KJ, Shin J, Zhang C, 
Makri G, Nauen D, Yu H, Guzman E, Chiang CH, Yoritomo N, Kaibuchi K, Zou J, Christian 
KM, Cheng L, Ross CA, Margolis RL, Chen G, Kosik KS, Song H, Ming GL: Synaptic 
dysregulation in a human iPS cell model of mental disorders. Nature 2014;515:414-8. 
13. Niwa M, Kamiya A, Murai R, Kubo K, Gruber AJ, Tomita K, Lu L, Tomisato S, Jaaro-Peled H, 
Seshadri S, Hiyama H, Huang B, Kohda K, Noda Y, O'Donnell P, Nakajima K, Sawa A, 
Nabeshima T: Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic 
maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010;65:480-9. 
14. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andrade M, 
Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A: Dominant-negative 
DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures 
translatable to humans. Proc Natl Acad Sci U S A 2007;104:14501-6. 
15. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, Mori S, Moran TH, 
Ross CA: Inducible expression of mutant human DISC1 in mice is associated with brain and 
behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 2008;13:173-86, 115. 
14 
16. Shen S, Lang B, Nakamoto C, Zhang F, Pu J, Kuan SL, Chatzi C, He S, Mackie I, Brandon NJ, 
Marquis KL, Day M, Hurko O, McCaig CD, Riedel G, St Clair D: Schizophrenia-related neural 
and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci 
2008;28:10893-904. 
17. Li W, Zhou Y, Jentsch JD, Brown RA, Tian X, Ehninger D, Hennah W, Peltonen L, Lonnqvist J, 
Huttunen MO, Kaprio J, Trachtenberg JT, Silva AJ, Cannon TD: Specific developmental 
disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes 
in mice. Proc Natl Acad Sci U S A 2007;104:18280-5. 
18. Kvajo M, McKellar H, Arguello PA, Drew LJ, Moore H, MacDermott AB, Karayiorgou M, 
Gogos JA: A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific 
alterations in neuronal architecture and cognition. Proc Natl Acad Sci U S A 2008;105:7076-81. 
19. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, 
Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, 
Gondo Y, Porteous DJ, Roder JC: Behavioral phenotypes of Disc1 missense mutations in mice. 
Neuron 2007;54:387-402. 
20. Johnson AW, Jaaro-Peled H, Shahani N, Sedlak TW, Zoubovsky S, Burruss D, Emiliani F, Sawa 
A, Gallagher M: Cognitive and motivational deficits together with prefrontal oxidative stress in a 
mouse model for neuropsychiatric illness. Proc Natl Acad Sci U S A 2013;110:12462-7. 
21. Kuroda K, Yamada S, Tanaka M, Iizuka M, Yano H, Mori D, Tsuboi D, Nishioka T, Namba T, 
Iizuka Y, Kubota S, Nagai T, Ibi D, Wang R, Enomoto A, Isotani-Sakakibara M, Asai N, Kimura 
K, Kiyonari H, Abe T, Mizoguchi A, Sokabe M, Takahashi M, Yamada K, Kaibuchi K: 
Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in 
the mouse. Hum Mol Genet 2011;20:4666-83. 
22. Brandon NJ, Sawa A: Linking neurodevelopmental and synaptic theories of mental illness 
through DISC1. Nat Rev Neurosci 2011;12:707-22. 
15 
23. Camargo LM, Collura V, Rain JC, Mizuguchi K, Hermjakob H, Kerrien S, Bonnert TP, Whiting 
PJ, Brandon NJ: Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity 
of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry 2007;12:74-86. 
24. Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y, Sawamura N, Park U, Kudo C, 
Okawa M, Ross CA, Hatten ME, Nakajima K, Sawa A: A schizophrenia-associated mutation of 
DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005;7:1167-78. 
25. Ishizuka K, Kamiya A, Oh EC, Kanki H, Seshadri S, Robinson JF, Murdoch H, Dunlop AJ, 
Kubo K, Furukori K, Huang B, Zeledon M, Hayashi-Takagi A, Okano H, Nakajima K, Houslay 
MD, Katsanis N, Sawa A: DISC1-dependent switch from progenitor proliferation to migration in 
the developing cortex. Nature 2011;473:92-6. 
26. Johnson ES: Protein modification by SUMO. Annu Rev Biochem 2004;73:355-82. 
27. Muller S, Hoege C, Pyrowolakis G, Jentsch S: SUMO, ubiquitin's mysterious cousin. Nat Rev 
Mol Cell Biol 2001;2:202-10. 
28. Mao Y, Sun M, Desai SD, Liu LF: SUMO-1 conjugation to topoisomerase I: A possible repair 
response to topoisomerase-mediated DNA damage. Proc Natl Acad Sci U S A 2000;97:4046-51. 
29. Bassi C, Ho J, Srikumar T, Dowling RJ, Gorrini C, Miller SJ, Mak TW, Neel BG, Raught B, 
Stambolic V: Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 
2013;341:395-9. 
30. Yan Q, Gong L, Deng M, Zhang L, Sun S, Liu J, Ma H, Yuan D, Chen PC, Hu X, Liu J, Qin J, 
Xiao L, Huang XQ, Zhang J, Li DW: Sumoylation activates the transcriptional activity of Pax-6, 
an important transcription factor for eye and brain development. Proc Natl Acad Sci U S A 
2010;107:21034-9. 
31. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F: A small ubiquitin-related polypeptide 
involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997;88:97-107. 
16 
32. Jakobs A, Koehnke J, Himstedt F, Funk M, Korn B, Gaestel M, Niedenthal R: Ubc9 fusion-
directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat 
Methods 2007;4:245-50. 
33. Kamiya A, Tan PL, Kubo K, Engelhard C, Ishizuka K, Kubo A, Tsukita S, Pulver AE, Nakajima 
K, Cascella NG, Katsanis N, Sawa A: Recruitment of PCM1 to the centrosome by the 
cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses. Arch Gen 
Psychiatry 2008;65:996-1006. 
34. Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K, Okawa M, Yamada N, Hatten 
ME, Snyder SH, Ross CA, Sawa A: Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation 
prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S 
A 2003;100:289-94. 
35. Ogawa F, Kasai M, Akiyama T: A functional link between Disrupted-In-Schizophrenia 1 and the 
eukaryotic translation initiation factor 3. Biochem Biophys Res Commun 2005;338:771-6. 
36. Eykelenboom JE, Briggs GJ, Bradshaw NJ, Soares DC, Ogawa F, Christie S, Malavasi EL, 
Makedonopoulou P, Mackie S, Malloy MP, Wear MA, Blackburn EA, Bramham J, McIntosh 
AM, Blackwood DH, Muir WJ, Porteous DJ, Millar JK: A t(1;11) translocation linked to 
schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that 
encode structurally altered, deleterious mitochondrial proteins. Hum Mol Genet 2012;21:3374-
86. 
37. Ogawa F, Malavasi EL, Crummie DK, Eykelenboom JE, Soares DC, Mackie S, Porteous DJ, 
Millar JK: DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal 
mitochondrial trafficking. Hum Mol Genet 2014;23:906-19. 
38. Tabata H, Nakajima K: Efficient in utero gene transfer system to the developing mouse brain 
using electroporation: visualization of neuronal migration in the developing cortex. Neuroscience 
2001;103:865-72. 
17 
39. Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK, Tassa C, Berry EM, Soda T, 
Singh KK, Biechele T, Petryshen TL, Moon RT, Haggarty SJ, Tsai LH: Disrupted in 
schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-
catenin signaling. Cell 2009;136:1017-31. 
40. Geiss-Friedlander R, Melchior F: Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 
2007;8:947-56. 
41. Sawamura N, Sawamura-Yamamoto T, Ozeki Y, Ross CA, Sawa A: A form of DISC1 enriched 
in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and 
substance/alcohol abuse. Proc Natl Acad Sci U S A 2005;102:1187-92. 
42. Sawamura N, Ando T, Maruyama Y, Fujimuro M, Mochizuki H, Honjo K, Shimoda M, Toda H, 
Sawamura-Yamamoto T, Makuch LA, Hayashi A, Ishizuka K, Cascella NG, Kamiya A, Ishida 
N, Tomoda T, Hai T, Furukubo-Tokunaga K, Sawa A: Nuclear DISC1 regulates CRE-mediated 
gene transcription and sleep homeostasis in the fruit fly. Mol Psychiatry 2008;13:1138-48, 1069. 
43. Soda T, Frank C, Ishizuka K, Baccarella A, Park YU, Flood Z, Park SK, Sawa A, Tsai LH: 
DISC1-ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by 
DISC1. Mol Psychiatry 2013;18:898-908. 
44. Xie Z, Sanada K, Samuels BA, Shih H, Tsai LH: Serine 732 phosphorylation of FAK by Cdk5 is 
important for microtubule organization, nuclear movement, and neuronal migration. Cell 
2003;114:469-82. 
45. Takahashi-Fujigasaki J, Arai K, Funata N, Fujigasaki H: SUMOylation substrates in neuronal 
intranuclear inclusion disease. Neuropathol Appl Neurobiol 2006;32:92-100. 
46. Tabata H, Kanatani S, Nakajima K: Differences of migratory behavior between direct progeny of 
apical progenitors and basal progenitors in the developing cerebral cortex. Cereb Cortex 
2009;19:2092-105. 
 
18 
 
Figure legends 
Fig. 1. SUMOylation of C-terminal DISC1 at lysine residue 643 (K643) in vitro 
a, DISC1 SUMOylation sites predicted by use of the ABGENT SUMOplot
TM
.  
b, In vitro SUMOylation assay with GST-tagged C-terminal DISC1 (DISC1-C). Proteins were separated 
on a 4-12 % Bis-Tris gradient gel. Coomassie blue-staining showed that DISC1-C was covalently 
conjugated to SUMO1, SUMO2, and SUMO3. Red arrowheads indicate SUMOylated forms of DISC1-
C.  
c, In vitro SUMOylation assay with GST-tagged C-terminal DISC1 (DISC1-C) or mutant C terminal 
DISC1 where K643 was substituted by alanine (DISC1-C-K643A). 8 % Tris-Glycine gel electrophoresis 
and immunoblotting showed that DISC1-C but not DISC1-C-K643A was SUMOylated. Red arrowheads 
indicate SUMOylated forms of DISC1-C.  
 
Fig. 2. SUMOylation of DISC1 at lysine residue 643 (K643) in cells 
a, Conjugation of HA-DISC1-C with FLAG-SUMO1 (SUMOylation of DISC1) was shown in COS7 
cells. COS7 cells were transfected with HA-DISC1-C and/or FLAG-SUMO1. Cell lysates were 
immunoprecipitated with anti-FLAG antibody and the immunoprecipitates were blotted with anti-HA 
antibody. Red arrowheads indicate SUMOylated forms of DISC1-C.  
b, COS7 cells were transfected with HA-DISC1-C or HA-DISC1-C-K643A. Cells with HA-DISC1-C 
showed a strong signal, which represents a SUMOylated form of DISC1-C, suggesting SUMOylation of 
DISC1 with endogenous SUMO protein. This signal was significantly abolished in cells transfected with 
HA-DISC1-C-K643A. Red arrowhead indicates SUMOylated forms of DISC1-C.  
c, SUMOylation of full-length DISC1 was shown in HEK293 cells by Ubc9 fusion-directed 
SUMOylation (UFDS) assay. SUMO1-GFP fusion was co-transfected with DISC1-Ubc9, an E2 SUMO 
conjugating enzyme fusion, or DISC1-Ubc9 (C93S), a dominant negative form of Ubc9 fusion, in 
19 
HEK293 cells. Cell lysates were immunoblotted with anti-DISC1 antibody. Red arrowhead indicates 
SUMOylated forms of DISC1.  
d, COS7 cells were co-transfected with HA-DISC1 or HA-DISC1-K643A together with FLAG-SUMO1 
and myc-Ubc9. Cell lysates were immunoprecipitated with anti-HA antibody and the 
immunoprecipitates were blotted with anti-FLAG antibody. Signals for SUMOylated full-length DISC1 
were observed in cells transfected with HA-DISC1 (red arrowheads), whereas almost no signals were 
found at the same size in cells transfected with HA-DISC1-K643A.  
 
Fig. 3. K640 SUMOylation site in mouse DISC1 (mDISC1), corresponding to K643 in human 
DISC1, is crucial for proper proliferation of neural progenitor cells (NPCs) in vivo 
Images show E15 brains that were electroporated with GFP together with control shRNA, mDISC1 
shRNA, mDISC1 shRNA + wild-type (wt) mDISC1, or mDISC1 shRNA + mDISC1-K640A at E13. 
BrdU was injected 2 h before brain extraction. The proportion of BrdU incorporating cells in the 
ventricular (VZ) and multipolar cell accumulation zone (MAZ) [46] in brains with mDISC1 shRNA, 
was significantly lower than that in brains with control shRNA. This phenotype was rescued by wt 
mDISC1 but not by mDISC1-K640A. Graph shows the proportion of GFP/BrdU double-positive cells 
over total GFP positive cells in the VZ/MAZ. Scale bar, 20µm. Error bars indicate s.e.m. *P<0.05. 
 




